Clinical manifestation and prognostic factors of 32 Japanese patients with autoimmune disease-associated diffuse large B-cell lymphoma

1 Division of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2 Department of Hematology, Kyoto First Red Cross Hospital, Kyoto, Japan, 3 Department of Hematology, Social Insurance Kyoto Hospital, Kyoto, Japan, 4 Department of Hematology, Kyoto Second Red Cross Hospital, Kyoto, Japan, 5 Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan, 6 Department of Hematology, Otsu Municipal Hospital, Otsu, Japan and 7 Department of Infl ammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan